Medea Biopharma
PrivateLast Round
Pre Seed
Dec 16, 2024
Total Funding Raised
$3.53M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Medea Biopharma is a biotechnology company that develops bacteriophage-based antimicrobial solutions for therapeutic and non-therapeutic applications in human health, veterinary medicine, and agriculture.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medea Biopharma Comparables
Compare Medea Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Invitris | 83% | |
| NexaBiome | 82% | |
| Tolka AI Therapeutics | 79% |
Medea Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Dec 16, 2024 | ||||
| Pre Seed | Dec 1, 2023 | ||||
| Grant | Sep 14, 2023 | ||||
| Accelerator | Jan 1, 2023 |
Medea Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Start2 Group | Accelerator |
| TechFounders | Accelerator |
| Singapore Management University's Institute of Innovation & Entrepreneurship | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 1279% MoM.
- Dec 16, 2024
$1.68M raised in Pre Seed round.
Medea Biopharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Medea Biopharma's valuation, stock price, and market status.
Is Medea Biopharma a public or private company?
Medea Biopharma is a private company.
What is the current stock price of Medea Biopharma?
Medea Biopharma is a private company, so its shares have no public market price. Caplight tracks Medea Biopharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Medea Biopharma worth (valuation)?
Valuation information for Medea Biopharma is not publicly available.
Can I buy Medea Biopharma stock?
Medea Biopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Medea Biopharma's last funding round?
Medea Biopharma's most recent funding round was Pre Seed on December 16, 2024.
Who are the main investors in Medea Biopharma?
Key investors in Medea Biopharma include TechFounders.
Will Medea Biopharma IPO soon?
No public IPO plans have been announced for Medea Biopharma.
How can I track Medea Biopharma secondary market activity?
Caplight tracks bids, offers, and trades in Medea Biopharma's shares on secondary markets.